Trademark Overview
On Monday, August 20, 2001, a trademark application was filed for TREZOLT with the United States Patent and Trademark Office. The USPTO has given the TREZOLT trademark a serial number of 76302084. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, August 20, 2002. This trademark is owned by Pfizer Inc.. The TREZOLT trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital, and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations
